A comparison of medication adherence of blonanserin and aripiprazole in schizophrenic patients: a multicenter, randomized, open-label study
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2019
Price : $35 *
At a glance
- Drugs Aripiprazole (Primary) ; Blonanserin (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms A-BLAS
- 01 Sep 2015 Status changed from recruiting to completed, according to results presented at the 28th Annual Congress of the European College of Neuropsychopharmacology.
- 01 Sep 2015 Results (n=27) presented at the 28th Annual Congress of the European College of Neuropsychopharmacology.
- 07 Jan 2014 New trial record